Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, while investors want to cash in by putting their hard-earned money into the most promising AI companies. However, prominent names in this fast-growing space have seen their shares soar in the past two years, and the valuations of some have become quite expensive.
Two AI healthcare stocks — Recursion Pharmaceuticals (RXRX -2.76%) and…
Article Source
https://www.fool.com/investing/2025/03/30/should-investors-buy-these-2-beaten-down-ai-stocks/
